ANALYST RECOMMENDATIONS : Adobe, AstraZeneca, Morgan Stanley, Oracle...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• Adobe: D.A. Davidson & Co initiated coverage with a recommendation of neutral. PT set to $350.
• AstraZeneca: Berenberg remains Buy with a price target raised from GBp 118 to GBp 126.
• Magellan Midstream: Barclays upgrades to overweight from equal-weight. PT up 12% to $59.
• Monarch Casino: Macquarie downgrades to neutral from outperform. PT up 2.2% to $81.
• Morgan Stanley: Citi downgrades to neutral from buy. PT up 3% to $100.
• Oracle:  D.A. Davidson & Co initiated coverage with a recommendation of neutral. PT set to $85.
• Salesforce: D.A. Davidson & Co initiated coverage with a recommendation of neutral. PT set to $150.
• Snowflake: Scotiabank initiated coverage with a recommendation of sector perform. PT set to $125.
• Unilever: Jefferies remains Buy with a price target raised from GBp 4500 to GBp 4850.
• Vertex Pharmaceuticals: Canaccord Genuity reinstated coverage with a recommendation of hold. PT set to $311, a 0.3% decrease from last price.
• Whitbread: Oddo BHF upgrades from Outperform to Neutral with a target of GBp 3500.
• Williams Co: Barclays downgrades to equal-weight from overweight. PT up 13% to $37.
• Willis Towers: Keefe, Bruyette & Woods upgrades to outperform from market perform. PT jumps 20% to $303.
• UGI: Barclays cut its recommendation to underweight from equal-weight. PT down 3.7% to $39.